News tagged with metastatic cancers

Regorafenib: Hint of minor added benefit

Regorafenib (trade name: Stivarga) has been approved in Germany since August 2013 for adults with metastatic colorectal cancer in whom previous treatments are no longer effective or for whom these alternatives are not an ...

Jan 10, 2014
popularity not rated yet | comments 0